<DOC>
	<DOCNO>NCT02357693</DOCNO>
	<brief_summary>The purpose study determine whether patient high risk postoperative nausea vomit benefit aprepitant , ondansetron dexamethasone perioperative period .</brief_summary>
	<brief_title>Neurokinin Receptor Antagonist Associated Ondansetron PONV</brief_title>
	<detailed_description>High risk surgical patient PONV , schedule laparoscopic surgery distribute two group : Group I receive aprepitant 80 mg per o Group II receive placebo per o , one hour surgery . In operating room , patient submit combined intravenous general anesthesia plus spinal anesthesia . All patient receive dexamethasone 4 mg ondansetron 4 mg intravenously surgical procedure . After surgery , patient monitor pain , nausea vomit 24 hour .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Neurokinin A</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Neurokinin-1 Receptor Antagonists</mesh_term>
	<criteria>high risk patient nausea vomit cardiovascular disease , hypersensibility drug involve study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>nausea , postoperative</keyword>
	<keyword>postoperative nausea</keyword>
	<keyword>postoperative vomiting</keyword>
	<keyword>vomiting , postoperative</keyword>
</DOC>